Login / Signup
Xuejun Fan
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 4
Top Topics
Genetic Diversity
Mesenchymal Stem Cells
Gene Therapy
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hong Jiang
,
Dong Ho Shin
,
Yanhua Yi
,
Xuejun Fan
,
Joy Gumin
,
Jiasen He
,
Andrew G Gillard
,
Frederick F Lang
,
Candelaria Gomez-Manzano
,
Juan Fueyo
Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity.
Cancer research communications
3 (6) (2023)
Hong Jiang
,
Dong Ho Shin
,
Yanhua Yi
,
Xuejun Fan
,
Joy Gumin
,
Jiasen He
,
Andrew G Gillard
,
Frederick F Lang
,
Candelaria Gomez-Manzano
,
Juan Fueyo
Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity.
Cancer research communications
3 (6) (2023)
Hong Jiang
,
Dong Ho Shin
,
Yanhua Yi
,
Xuejun Fan
,
Joy Gumin
,
Jiasen He
,
Andrew G Gillard
,
Frederick F Lang
,
Candelaria Gomez-Manzano
,
Juan Fueyo
Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity.
Cancer research communications
3 (6) (2023)
Hong Jiang
,
Dong Ho Shin
,
Yanhua Yi
,
Xuejun Fan
,
Joy Gumin
,
Jiasen He
,
Andrew G Gillard
,
Frederick F Lang
,
Candelaria Gomez-Manzano
,
Juan Fueyo
Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity.
Cancer research communications
3 (6) (2023)